These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 18074929)
1. Get informed consent for risky drugs. Johnson LJ Med Econ; 2007 Nov; 84(21):20. PubMed ID: 18074929 [No Abstract] [Full Text] [Related]
2. Drug information for patients. Duties of the manufacturer, pharmacist, physician, and hospital. Brushwood DB; Simonsmeier LM J Leg Med; 1986 Sep; 7(3):279-340. PubMed ID: 3490527 [No Abstract] [Full Text] [Related]
3. This prescription may be hazardous to your health: who is accountable to the patient? Walsh CB J Clin Psychopharmacol; 1993 Feb; 13(1):68-70. PubMed ID: 8486819 [No Abstract] [Full Text] [Related]
4. How to reduce the chances of malpractice legal action. Gonzalez R Med Malpract Cost Containment J; 1980 Jan; 1(4):349-55. PubMed ID: 10245239 [No Abstract] [Full Text] [Related]
5. Risk management of marketed drugs: FDA and the interface with the practice of medicine. Uhl K; Honig P Pharmacoepidemiol Drug Saf; 2001 May; 10(3):205-8. PubMed ID: 11501332 [No Abstract] [Full Text] [Related]
6. [Responsibility for patient education in drug therapy from the viewpoint of the pharmaceutical industry]. Sander A Z Arztl Fortbild (Jena); 1994 Dec; 88(12):1061-3. PubMed ID: 7716983 [No Abstract] [Full Text] [Related]
12. Informed consent--more than a form. Baum N J Med Pract Manage; 2006; 22(3):145-8. PubMed ID: 17260911 [TBL] [Abstract][Full Text] [Related]
13. Legal liability for medical innovation. Epstein RA Spec Law Dig Health Care (Mon); 1989 May; (123):7-27. PubMed ID: 10292879 [No Abstract] [Full Text] [Related]
14. Malpractice issues in radiology. Informed consent. Berlin L AJR Am J Roentgenol; 1997 Jul; 169(1):15-8. PubMed ID: 9207493 [No Abstract] [Full Text] [Related]
15. Lack of informed consent in medical malpractice and product liability cases: the burden of presenting evidence. Seidelson DE Spec Law Dig Health Care (Mon); 1989 Apr; (122):7-37. PubMed ID: 10292878 [No Abstract] [Full Text] [Related]
16. View from the Nation's Capital. "Off-label" uses of approved drugs: limits on physicians' prescribing behavior. Appler WD; McMann GL J Clin Psychopharmacol; 1989 Oct; 9(5):368-70. PubMed ID: 2794099 [No Abstract] [Full Text] [Related]
17. Red sky in the morning: modifying prescription drug labels as a result of postmarket surveillance. Jacobson JD; Feigal D Food Drug Law J; 2007; 62(3):529-46. PubMed ID: 17915395 [No Abstract] [Full Text] [Related]